{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T21:22:31Z","timestamp":1794950551966,"version":"4.9.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T00:00:00Z","timestamp":1779580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Patient Centered Outcomes Institute","award":["PCS-1402-10749"],"award-info":[{"award-number":["PCS-1402-10749"]}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA237533"],"award-info":[{"award-number":["R01CA237533"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"crossref","award":["SPEC-18-006, SPEC-22-018, SPEC-24-026"],"award-info":[{"award-number":["SPEC-18-006, SPEC-22-018, SPEC-24-026"]}],"id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000867","name":"Robert Wood Johnson Foundation","doi-asserted-by":"publisher","award":["Pioneer Pitch Award 71864"],"award-info":[{"award-number":["Pioneer Pitch Award 71864"]}],"id":[{"id":"10.13039\/100000867","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021686","name":"Safeway Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021686","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bright Pink"},{"DOI":"10.13039\/100001252","name":"Mount Zion Health Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001368","name":"V Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001368","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sanford Foundation"},{"DOI":"10.13039\/100011800","name":"Salesforce","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011800","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Breast Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The Women Informed to Screen Depending on Measures of risk (WISDOM) Study (clinicaltrials.gov NCT02620852, 2016-08-31) is pragmatic randomized controlled trial evaluating risk assessment to inform the age to start, frequency and modality of breast cancer screening and risk reduction. The WISDOM Study uses a preference-tolerant design, enabling women who decline randomization to self-select their screening arm. The risk-based arm included comprehensive breast cancer risk assessment using the Breast Cancer Surveillance Consortium (BCSC) model and genetics. From August 2016 to February 2023, WISDOM enrolled a large, diverse, nationwide cohort of 46,403 participants - 77% non-Hispanic (NH) White, 9% Hispanic, 6% (NH) Black, and 5% (NH) Asian; demographic diversity increased over time. Mean age at baseline was 54 years. 28,372 (61%) were randomized, while 89% of those who self-selected their screening arm chose risk-based screening. The preference-tolerant design captured real-world screening preferences while maintaining scientific rigor and demonstrated strong preference for risk-based screening.<\/jats:p>","DOI":"10.1038\/s41523-026-00952-x","type":"journal-article","created":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T00:14:16Z","timestamp":1779581656000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["WISDOM randomized trial comparing risk-based versus annual breast cancer screening: study cohort characteristics and design"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9639-4053","authenticated-orcid":false,"given":"Allison","family":"Fiscalini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirkpatrick","family":"Fergus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Hiatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Naeim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren T.","family":"Scheuner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"van \u2018t Veer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Z.","family":"LaCroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander D.","family":"Borowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olufunmilayo I.","family":"Olopade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah L.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Esserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Lancaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Heditsian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susie","family":"Brain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah L.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine S.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Wenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Madlensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Tice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwey","family":"Shieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Ziv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignesh A.","family":"Arasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Anton-Culver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia P.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim F.","family":"Rhoads","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Badal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hogarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Petruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene A.","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Leggat-Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffanie","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Atamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Adduci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey B.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Eklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Athena\/WISDOM Network Collaborators and Advocate Partners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah P.","family":"Sabacan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9202-4568","authenticated-orcid":false,"given":"Laura","family":"Esserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,24]]},"reference":[{"key":"952_CR1","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/0140-6736(93)91067-V","volume":"341","author":"L Nystr\u00f6m","year":"1993","unstructured":"Nystr\u00f6m, L. et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 341, 973\u2013978 (1993).","journal-title":"Lancet"},{"key":"952_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/jncimono\/1997.22.27","volume":"1997","author":"S Shapiro","year":"1997","unstructured":"Shapiro, S. Periodic screening for breast cancer: the HIP randomized controlled trial. JNCI Monogr. 1997, 27\u201330 (1997).","journal-title":"JNCI Monogr."},{"key":"952_CR3","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0140-6736(02)08020-0","volume":"359","author":"L Nystr\u00f6m","year":"2002","unstructured":"Nystr\u00f6m, L. et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 359, 909\u2013919 (2002).","journal-title":"Lancet"},{"key":"952_CR4","doi-asserted-by":"publisher","unstructured":"G\u00f8tzsche, P. C. & Nielsen, M. Screening for breast cancer with mammography. Cochrane Database Syst. Rev. CD001877 https:\/\/doi.org\/10.1002\/14651858.cd001877.pub2 (2009).","DOI":"10.1002\/14651858.cd001877.pub2"},{"key":"952_CR5","doi-asserted-by":"publisher","first-page":"g366","DOI":"10.1136\/bmj.g366","volume":"348","author":"AB Miller","year":"2014","unstructured":"Miller, A. B. et al. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. Br. Med. J. 348, g366 (2014).","journal-title":"Br. Med. J."},{"key":"952_CR6","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S1470-2045(20)30398-3","volume":"21","author":"SW Duffy","year":"2020","unstructured":"Duffy, S. W. et al. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial. Lancet Oncol. 21, 1165\u20131172 (2020).","journal-title":"Lancet Oncol."},{"key":"952_CR7","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3390\/life14060777","volume":"14","author":"L Katsika","year":"2024","unstructured":"Katsika, L. et al. Screening for breast cancer: a comparative review of guidelines. Life 14, 777 (2024).","journal-title":"Life"},{"key":"952_CR8","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1016\/S0140-6736(24)00425-2","volume":"403","author":"S Delaloge","year":"2024","unstructured":"Delaloge, S., Khan, S. A., Wesseling, J. & Whelan, T. Ductal carcinoma in situ of the breast: finding the balance between overtreatment and undertreatment. Lancet 403, 2734\u20132746 (2024).","journal-title":"Lancet"},{"key":"952_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/0003-4819-155-1-201107050-00003","volume":"155","author":"JT Schousboe","year":"2011","unstructured":"Schousboe, J. T., Kerlikowske, K., Loh, A. & Cummings, S. R. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann. Intern. Med. 155, 10 (2011).","journal-title":"Ann. Intern. Med."},{"key":"952_CR10","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/bjc.2011.118","volume":"104","author":"N Pashayan","year":"2011","unstructured":"Pashayan, N. et al. Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. Br. J. Cancer 104, 1656\u20131663 (2011).","journal-title":"Br. J. Cancer"},{"key":"952_CR11","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrclinonc.2016.50","volume":"13","author":"Y Shieh","year":"2016","unstructured":"Shieh, Y. et al. Population-based screening for cancer: hope and hype. Nat. Rev. Clin. Oncol. 13, 550\u2013565 (2016).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"952_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-017-0035-5","volume":"3","author":"LJ Esserman","year":"2017","unstructured":"Esserman, L. J. Athena Wisdom Study Investigators & Athena, I. The WISDOM Study: breaking the deadlock in the breast cancer screening debate. NPJ Breast Cancer 3, 34 (2017).","journal-title":"NPJ Breast Cancer"},{"key":"952_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pky067","volume":"2","author":"M Eklund","year":"2018","unstructured":"Eklund, M. et al. The WISDOM personalized breast cancer screening trial: simulation study to assess potential bias and analytic approaches. JNCI Cancer Spectr. 2, pky067 (2018).","journal-title":"JNCI Cancer Spectr."},{"key":"952_CR14","doi-asserted-by":"publisher","first-page":"S383","DOI":"10.1016\/j.jacr.2017.08.044","volume":"14","author":"Expert Panel on","year":"2017","unstructured":"Panel on, E. xpert et al. ACR Appropriateness Criteria\u00ae Breast Cancer Screening. J. Am. Coll. Radiol. 14, S383\u2013S390 (2017).","journal-title":"J. Am. Coll. Radiol."},{"key":"952_CR15","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1200\/JCO.2015.60.8869","volume":"33","author":"JA Tice","year":"2015","unstructured":"Tice, J. A. et al. Breast density and benign breast disease: risk assessment to identify women at high risk of breast cancer. J. Clin. Oncol. 33, 3137\u20133143 (2015).","journal-title":"J. Clin. Oncol."},{"key":"952_CR16","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s10549-019-05167-2","volume":"175","author":"JA Tice","year":"2019","unstructured":"Tice, J. A. et al. Validation of the breast cancer surveillance consortium model of breast cancer risk. Breast Cancer Res. Tr. 175, 519\u2013523 (2019).","journal-title":"Breast Cancer Res. Tr."},{"key":"952_CR17","doi-asserted-by":"publisher","first-page":"djw290","DOI":"10.1093\/jnci\/djw290","volume":"109","author":"Y Shieh","year":"2017","unstructured":"Shieh, Y. et al. Breast cancer screening in the precision medicine era: risk-based screening in a population-based trial. J. Natl. Cancer Inst. 109, djw290 (2017).","journal-title":"J. Natl. Cancer Inst."},{"key":"952_CR18","doi-asserted-by":"crossref","unstructured":"Esserman, L. J. et al. Risk-based and annual breast cancer screening: the WISDOM randomized trial. JAMA Accepted for publication. 335, 763\u2013774 (2026).","DOI":"10.1001\/jama.2025.24865"},{"key":"952_CR19","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMp1802313","volume":"378","author":"AJH Kind","year":"2018","unstructured":"Kind, A. J. H. & Buckingham, W. R. Making neighborhood-disadvantage metrics accessible \u2014 the neighborhood Atlas. N. Engl. J. Med. 378, 2456\u20132458 (2018).","journal-title":"N. Engl. J. Med."},{"key":"952_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-025-01524-7","volume":"17","author":"KB Fergus","year":"2025","unstructured":"Fergus, K. B. et al. Integrating breast cancer polygenic risk scores at scale in the WISDOM Study: a national randomized personalized screening trial. Genome Med. 17, 97 (2025).","journal-title":"Genome Med."},{"key":"952_CR21","doi-asserted-by":"crossref","unstructured":"Fergus, K. B. et al. Germline Pathogenic Variants Among Women Without a History of Breast Cancer: A Secondary Analysis of the WISDOM Randomized Clinical Trial. JAMA Intern. Med. 186, 344\u2013352 (2026).","DOI":"10.1001\/jamainternmed.2025.7323"},{"key":"952_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-089155","volume":"14","author":"S Jeffers","year":"2024","unstructured":"Jeffers, S., Pilnick, A. & Armstrong, N. Decisions to decline breast screening and\/or breast cancer treatment based on the potential harms of overdiagnosis and overtreatment: a qualitative study. BMJ Open 14, e089155 (2024).","journal-title":"BMJ Open"},{"key":"952_CR23","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1002\/pon.5211","volume":"28","author":"Z Xie","year":"2019","unstructured":"Xie, Z. et al. Risk estimation, anxiety, and breast cancer worry in women at risk for breast cancer: a single-arm trial of personalized risk communication. PsychoOncol 28, 2226\u20132232 (2019).","journal-title":"PsychoOncol"},{"key":"952_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1159\/000540680","volume":"27","author":"L Riddle","year":"2024","unstructured":"Riddle, L. et al. Receiving a pathogenic variant in a population breast cancer screening trial: a mixed method study. Public Health. Genom. 27, 177\u2013196 (2024).","journal-title":"Public Health. Genom."},{"key":"952_CR25","doi-asserted-by":"publisher","unstructured":"Fergus, K. et al. Germline pathogenic variants in the personalized screening arm of the WISDOM Study. JAMA Intern. Med. Accepted for publication, Sept 2025. https:\/\/doi.org\/10.1001\/jamainternmed.2025.7323.","DOI":"10.1001\/jamainternmed.2025.7323"},{"key":"952_CR26","volume":"12","author":"R Shen","year":"2023","unstructured":"Shen, R. et al. Internet versus noninternet participation in a decentralized clinical trial: lessons from the ADAPTABLE study. J. Am. Hear. Assoc. Cardiovasc. Cerebrovasc. Dis. 12, e027899 (2023).","journal-title":"J. Am. Hear. Assoc. Cardiovasc. Cerebrovasc. Dis."},{"key":"952_CR27","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1001\/jama.2022.0875","volume":"327","author":"J Whyte","year":"2022","unstructured":"Whyte, J. Racial and ethnic representation of participants in US clinical trials of new drugs and biologics. JAMA 327, 985\u2013985 (2022).","journal-title":"JAMA"},{"key":"952_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09484-6","volume":"22","author":"A Roux","year":"2022","unstructured":"Roux, A. et al. Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the \u201cMy Personal Breast Screening\u201d (MyPeBS) randomised clinical trial. BMC Cancer 22, 507 (2022).","journal-title":"BMC Cancer"},{"key":"952_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-13848-z","volume":"25","author":"A Roux","year":"2025","unstructured":"Roux, A. et al. Acceptability of risk-based breast cancer screening among professionals and healthcare providers from 6 countries contributing to the MyPeBS study. BMC Cancer 25, 483 (2025).","journal-title":"BMC Cancer"},{"key":"952_CR30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10549-013-2612-0","volume":"140","author":"The Athena Breast Health Network et al.","year":"2013","unstructured":"The Athena Breast Health Network et al. The Athena Breast Health Network: developing a rapid learning system in breast cancer prevention, screening, treatment, and care. Breast Cancer Res. Tr. 140, 417\u2013425 (2013).","journal-title":"Breast Cancer Res. Tr."},{"key":"952_CR31","doi-asserted-by":"publisher","first-page":"djv036","DOI":"10.1093\/jnci\/djv036","volume":"107","author":"N Mavaddat","year":"2015","unstructured":"Mavaddat, N. et al. Prediction of breast cancer risk based on profiling with common genetic variants. J. Natl. Cancer Inst. 107, djv036 (2015).","journal-title":"J. Natl. Cancer Inst."},{"key":"952_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ajhg.2018.11.002","volume":"104","author":"N Mavaddat","year":"2019","unstructured":"Mavaddat, N. et al. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes. Am. J. Hum. Genet. 104, 21\u201334 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"952_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00306-9","volume":"7","author":"YS Huilgol","year":"2021","unstructured":"Huilgol, Y. S. et al. Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registry. npj Breast Cancer 7, 102 (2021).","journal-title":"npj Breast Cancer"},{"key":"952_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00288-8","volume":"7","author":"H Keane","year":"2021","unstructured":"Keane, H. et al. Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial. npj Breast Cancer 7, 78 (2021).","journal-title":"npj Breast Cancer"},{"key":"952_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-024-00681-z","volume":"10","author":"T Wang","year":"2024","unstructured":"Wang, T. et al. Validation study of risk-reduction activities after personalized breast cancer education tool in the WISDOM study. npj Breast Cancer 10, 90 (2024).","journal-title":"npj Breast Cancer"},{"key":"952_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1472-6947-14-4","volume":"14","author":"EM Ozanne","year":"2014","unstructured":"Ozanne, E. M., Howe, R., Omer, Z. & Esserman, L. J. Development of a personalized decision aid for breast cancer risk reduction and management. BMC Med. Inf. Decis. 14, 4 (2014).","journal-title":"BMC Med. Inf. Decis."},{"key":"952_CR37","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/jgc4.1051","volume":"28","author":"EM Ozanne","year":"2019","unstructured":"Ozanne, E. M. et al. Evaluation of National Comprehensive Cancer Network guideline-based Tool for Risk Assessment for breast and ovarian Cancer (N-TRAC): a patient-reported survey for genetic high-risk assessment for breast and ovarian cancers in women. J. Genet. Couns. 28, 507\u2013515 (2019).","journal-title":"J. Genet. Couns."},{"key":"952_CR38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1524-4741.2007.00395.x","volume":"13","author":"EM Ozanne","year":"2007","unstructured":"Ozanne, E. M., Annis, C., Adduci, K., Showstack, J. & Esserman, L. Pilot trial of a computerized decision aid for breast cancer prevention. Breast J. 13, 147\u2013154 (2007).","journal-title":"Breast J."}],"container-title":["npj Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00952-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00952-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00952-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T22:42:44Z","timestamp":1786920164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00952-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,24]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["952"],"URL":"https:\/\/doi.org\/10.1038\/s41523-026-00952-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7665355\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-7665355\/v2","asserted-by":"object"}]},"ISSN":["2374-4677"],"issn-type":[{"value":"2374-4677","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,24]]},"assertion":[{"value":"20 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Olufunmilayo Olopade is co-founder of CancerIQ, owns stock in TempusAI, and was provided research support from the Color Foundation for genetic testing in Nigeria. Laura van \u2018T Veer is a part-time employee and stockholder of Agendia NV. Laura J. Esserman is a Medical Advisory Panel member for Blue Cross Blue Shield and has received consulting fees from UpToDate. Lisa Madlensky is on the clinical advisory council for VieCure. Michael Hogarth is a medical informatics advisor for Medeloop.ai, Lifelink, and Virta Health. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"108"}}